A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
Study sponsor: Nektar Therapeutics · NKTR
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-01-10Actual
Enrollment · participants291Actual
Source updated2024-04-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.